Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial.
Authors
Jönsson L, Regnier SA, Kymes S, Awad SF, Talon B, Lee XY, Goadsby PJ
Abstract
This post hoc analysis aimed to estimate eptinezumab’s therapeutic effect on health utilities and determined to which extent monthly migraine days (MMDs) explain changes in health utilities.
